Evidence map›Paper›PMID 30082769›Full record

ArticleCell death and differentiation2019

PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

Fu-Chun Huo, Yao-Jie Pan, Tong-Tong Li, Jie Mou, Dong-Sheng Pei

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. The Role of the p21-Activated Kinase Family in Tumor Immunity.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. PAK5-stabilized Smuc confers renal cell carcinoma metastasis.Clinical and translational medicine · 2021
    Article
  16. Article
  17. Article
  18. METTL3-mediated mOncogene · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fu-Chun Huo *Department of pathology, Xuzhou Medical University, Xuzhou, 221004, China.
Yao-Jie Pan *Department of Oncology, The Affiliated Yancheng Hospital of Medicine School of Southeast University, Yancheng, 224001, China.
Tong-Tong LiDepartment of pathology, Xuzhou Medical University, Xuzhou, 221004, China.
Jie MouSchool of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China. mou.jie@126.com.
Dong-Sheng PeiDepartment of pathology, Xuzhou Medical University, Xuzhou, 221004, China. dspei@xzhmu.edu.cn.
Xuzhou Medical College · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p21-activated kinase 5 (PAK5) is involved in several oncogenic signaling pathways and its amplification or overexpression has been found in various types of cancer; however, the pathophysiologic role of PAK5 in cervical cancer (CC) remains elusive. This study aims to elucidate the effects of PAK5 on CC metastasis and its specific regulation mechanism. We performed western blotting and immunohistochemistry (IHC) analysis and found that the expression levels of PAK5 were significantly upregulated in CC cells and tissues. In addition, statistical analysis via IHC showed that increased PAK5 significantly correlated with CC progression. Mn

Indexed as

Cell MovementCell ProliferationFemaleHeLa CellsHumansMatrix Attachment Region Binding Proteinsp21-Activated KinasesPhosphorylationTumor Cells, CulturedUterine Cervical NeoplasmsWound HealingMatrix Attachment Region Binding Proteinsp21-Activated KinasesPAK5 protein, humanSATB1 protein, human

Identifiers

PMID30082769
PMCPMC6748095
OpenAlexW2885651541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.